Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Angiogenesis inhibition is an effective adjuvant therapeutic strategy in neuroblastoma (NB) preclinical models

Angiogenesis inhibition is an effective adjuvant therapeutic strategy in neuroblastoma (NB) preclinical models. Advances in Neuroblastoma Research Proceeddings. 2002; 87.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.